Literature DB >> 16640550

The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma.

Richard A Scolyer, John F Thompson, Helen M Shaw, Stanley W McCarthy.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16640550     DOI： 10.1111/j.0303-6987.2006.00452.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN： 0303-6987            Impact factor:   1.587


× No keyword cloud information.
  4 in total

1.  Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.

Authors:  John F Thompson; Seng-Jaw Soong; Charles M Balch; Jeffrey E Gershenwald; Shouluan Ding; Daniel G Coit; Keith T Flaherty; Phyllis A Gimotty; Timothy Johnson; Marcella M Johnson; Stanley P Leong; Merrick I Ross; David R Byrd; Natale Cascinelli; Alistair J Cochran; Alexander M Eggermont; Kelly M McMasters; Martin C Mihm; Donald L Morton; Vernon K Sondak
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

2.  Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.

Authors:  Charles M Balch; Jeffrey E Gershenwald; Seng-Jaw Soong; John F Thompson; Shouluan Ding; David R Byrd; Natale Cascinelli; Alistair J Cochran; Daniel G Coit; Alexander M Eggermont; Timothy Johnson; John M Kirkwood; Stanley P Leong; Kelly M McMasters; Martin C Mihm; Donald L Morton; Merrick I Ross; Vernon K Sondak
Journal:  J Clin Oncol       Date:  2010-04-05       Impact factor: 44.544

3.  Pitfalls and important issues in the pathologic diagnosis of melanocytic tumors.

Authors:  Stanley W McCarthy; Richard A Scolyer
Journal:  Ochsner J       Date:  2010

4.  [Mitosis in early invasive malignant melanoma. How reliable is histogenetic classification at stage pT1?].

Authors:  H Bösmüller; S Haitchi-Petnehazy; T Hintringer; T Mentzel
Journal:  Pathologe       Date:  2012-03       Impact factor: 1.011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.